[Form 4] ALLISON TRANSMISSION HOLDINGS, INC. Insider Trading Activity
Rhea-AI Filing Summary
Allison Transmission Holdings insider Form 4 shows Chief Operating Officer and director G. Frederick Bohley purchased 3,000 shares of Allison Transmission Holdings Inc. (ALSN) on 08/14/2025 at a weighted-average price of $89.4999 per share. After the purchase the reporting person beneficially owns 99,074 shares directly and 360 shares indirectly through a spouse. The filing was executed by an attorney-in-fact on 08/15/2025 and discloses that the reported price is a weighted average of purchases between $88.49 and $88.50.
Positive
- Officer open-market purchase: COO and director acquired 3,000 shares, increasing direct holdings to 99,074 shares.
- Transparent pricing disclosure: Filing explains weighted-average price and provides the per-share range ($88.49–$88.50).
Negative
- None.
Insights
TL;DR: Insider purchase of 3,000 shares at ~$89.50 increases direct holdings to 99,074 shares, a modest positive signal.
The Form 4 documents a purchase by the company's COO and director, indicating a direct acquisition rather than an exercise or derivative transaction. The weighted-average price of $89.4999 and the disclosed price range ($88.49–$88.50) show the trades occurred in narrow increments. While the absolute size (3,000 shares) is small relative to large-cap holdings, insider purchases are generally viewed as alignment with shareholder interests because they increase personal exposure to company equity.
TL;DR: Filing correctly reports officer's open-market purchase and beneficial ownership; routine disclosure with no governance red flags.
The Form 4 contains required elements: reporting person details, relationship to issuer (COO and director), transaction date, transaction code (P for open-market purchase), number of shares acquired, resulting beneficial ownership, and an explanatory footnote on the weighted-average price. The signature was executed by an attorney-in-fact. There are no indications of derivative transactions, plan-based purchases, or irregular reporting in the disclosed information.